Construction of a Live-Attenuated HIV-1 Vaccine through Genetic Code Expansion

Authors


  • This work was supported by a grant from the Nebraska Research Initiative and a New Faculty Startup Fund to J.G. from the Chemistry Department of the University of Nebraska–Lincoln.

Abstract

A safe and effective vaccine against human immunodeficiency virus type 1 (HIV-1) is urgently needed to combat the worldwide AIDS pandemic, but still remains elusive. The fact that uncontrolled replication of an attenuated vaccine can lead to regaining of its virulence creates safety concerns precluding many vaccines from clinical application. We introduce a novel approach to control HIV-1 replication, which entails the manipulation of essential HIV-1 protein biosynthesis through unnatural amino acid (UAA*)-mediated suppression of genome-encoded blank codon. We successfully demonstrate that HIV-1 replication can be precisely turned on and off in vitro.

Ancillary